CSIRO Health & Biosecurity, Canberra, ACT 2602, Australia.
CSIRO Oceans & Atmosphere, Hobart, TAS 7004, Australia.
Sensors (Basel). 2021 Oct 5;21(19):6625. doi: 10.3390/s21196625.
Antimicrobial resistance (AMR) is threatening modern medicine. While the primary cost of AMR is paid in the healthcare domain, the agricultural and environmental domains are also reservoirs of resistant microorganisms and hence perpetual sources of AMR infections in humans. Consequently, the World Health Organisation and other international agencies are calling for surveillance of AMR in all three domains to guide intervention and risk reduction strategies. Technologies for detecting AMR that have been developed for healthcare settings are not immediately transferable to environmental and agricultural settings, and limited dialogue between the domains has hampered opportunities for cross-fertilisation to develop modified or new technologies. In this feature, we discuss the limitations of currently available AMR sensing technologies used in the clinic for sensing in other environments, and what is required to overcome these limitations.
抗菌药物耐药性(AMR)正在威胁现代医学。尽管 AMR 的主要代价是在医疗保健领域支付的,但农业和环境领域也是耐药微生物的储存库,因此也是人类 AMR 感染的永久来源。因此,世界卫生组织和其他国际机构呼吁对所有三个领域的 AMR 进行监测,以指导干预和降低风险的策略。为医疗保健环境开发的用于检测 AMR 的技术不能立即转移到环境和农业环境中,而且这些领域之间的对话有限,阻碍了交叉授粉以开发改良或新技术的机会。在这篇特写中,我们讨论了目前在临床上用于检测其他环境的 AMR 传感技术的局限性,以及克服这些局限性所需的条件。